期刊
JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY
卷 9, 期 6, 页码 585-592出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcct.2015.07.001
关键词
Extracellular space; Cardiac imaging techniques; CMR; CCT; Amyloidosis
资金
- NIHR, UK [NIHR-DRF- 2013-06-102/NIHR-DRF- 2011-04-008]
- British Heart Foundation [FS/12/56/29723, FS/10/72/28568]
- GlaxoSmithKline
- UK Department of Health National Institute for Health Research Biomedical Research Centers funding scheme
- National Institutes of Health Research (NIHR) [DRF-2011-04-008] Funding Source: National Institutes of Health Research (NIHR)
- British Heart Foundation [FS/10/40/28260, FS/12/56/29723, FS/10/72/28568] Funding Source: researchfish
- National Institute for Health Research [DRF-2011-04-008, NF-SI-0513-10019, DRF-2013-06-102] Funding Source: researchfish
Background: Cardiac involvement determines outcome in patients with systemic amyloidosis. There is major unmet need for quantification of cardiac amyloid burden, which is currently only met in part through semi-quantitative bone scintigraphy or Cardiovascular Magnetic Resonance (CMR), which measures ECVCMR. Other accessible tests are needed. Objectives: To develop cardiac computed tomography to diagnose and quantify cardiac amyloidosis by measuring the myocardial Extracellular Volume, ECVCT. Methods: Twenty-six patients (21 male, 64 +/- 14 years) with a biopsy-proven systemic amyloidosis (ATTR n = 18; AL n = 8) were Compared with twenty-seven patients (19 male, 68 +/- 8 years) with severe aortic stenosis (AS). All patients had undergone echocardiography, bone scintigraphy, NT-pro-BNP measurement and EQ-CMR. Dynamic Equilibrium CT (DynEQ-CT) was performed using a prospectively gated cardiac scan prior to and after (5 and 15 minutes) a standard Iodixanol (1 ml/kg) bolus to measure ECVCT. ECVCT was compared to the reference ECVCMR and conventional amyloid measures: bone scintigraphy and clinical markers of cardiac amyloid severity (NT-pro-BNP, Troponin, LVEF, LV mass, LA and RA area). Results: ECVCT and ECVCMR results were well correlated (r(2) = 0.85 vs r(2) = 0.74 for 5 and 15 minutes post bolus respectively). ECVCT was higher in amyloidosis than AS (0.54 +/- 0.11 vs 0.28 +/- 0.04, p<0.001) with no overlap. ECVCT tracked clinical markers of cardiac amyloid severity (NT-pro-BNP, Troponin, LVEF, LV mass, LA and RA area), and bone scintigraphy amyloid burden (p<0.001). Conclusion: Dynamic Equilibrium CT, a 5 minute contrast-enhanced gated cardiac CT, has potential for non-invasive diagnosis and quantification of cardiac amyloidosis. (C) 2015 The Authors. Published by Elsevier Inc. on behalf of Society of Cardiovascular Computed Tomography.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据